A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

2015 Medicare Part D Formulary Search By Drug Letter

This is archive material for research purposes. Please see PDPFinder.com or MAFinder.com for current plans.
Select a Letter below:
Links to Summaries by State for LTC Drugs on LIS/SNP Plans:
AK  AL  AR  AZ  CA  CO  CT  DC  DE  FL  GA  HI  IA  ID  IL  IN  KS  KY  LA  MA  MD  ME  MI  MN  MO  MS  MT  NC  ND  NE  NH  NJ  NM  NV  NY  OH  OK  OR  PA  PR  RI  SC  SD  TN  TX  UT  VA  VT  WA  WI  WV  WY

Drug Names Containing the Letter Q in Alphabetical Order.
Example: Lipitor® is found on letter page "L" as well as letter page "A" for Atorvastatin.

Drug Name
PackagingNDCOn This Nbr of 2015 Formularies
PDPsMAPDs
ACCUPRIL 10MG TABLET
(Quinapril HCl)
90 BOT000710530239
PDPs
28
MAPDs
ACCUPRIL 20MG TABLET
(Quinapril HCl)
90 BOT000710532239
PDPs
28
MAPDs
ACCUPRIL 40MG TABLET
(Quinapril HCl)
90 BOT000710535239
PDPs
28
MAPDs
ACCUPRIL 5MG TABLET
(Quinapril HCl)
90 BOT000710527239
PDPs
28
MAPDs
ACCURETIC 10-12.5MG TABLET
(Quinapril-Hydrochlorothiazide)
90 BOT0007102222311
PDPs
29
MAPDs
ACCURETIC 20-12.5MG TABLET
(Quinapril-Hydrochlorothiazide)
90 BOT0007102202311
PDPs
29
MAPDs
ACCURETIC 20-25MG TABLET
(Quinapril-Hydrochlorothiazide)
90 BOT0007102232311
PDPs
29
MAPDs
GARDASIL SYRINGE
(Quadrivalent Human Papillomavirus (HPV) Recombinant Vac)
   0000641090262
PDPs
315
MAPDs
GARDASIL VIAL
(Quadrivalent Human Papillomavirus (HPV) Recombinant Vac)
1 X 0.5 ML VIAL0000640450067
PDPs
347
MAPDs
GARDASIL 9 VIAL
(Quadrivalent Human Papillomavirus (HPV) Recombinant Vac)
   0000641190365
PDPs
316
MAPDs
GARDASIL 9 SYRINGE
(Quadrivalent Human Papillomavirus (HPV) Recombinant Vac)
   0000641210265
PDPs
309
MAPDs
QNASL CHILDREN'S 40 MCG SPRAY
(contains Beclomethasone)
   593100206067
PDPs
70
MAPDs
QNASL 80 MCG NASAL SPRAY
(contains Beclomethasone)
8.7 GM  593100210127
PDPs
76
MAPDs
QUADRACEL DTAP-IPV VIAL
(Diphtheria, Tetanus Toxoids, Acellular Pertussis, and Inactivated Poliovirus Vaccine)
   4928105625851
PDPs
259
MAPDs
Qualaquin 324mg/1 30 CAPSULE BOTTLE, PLASTIC
(Quinine Sulfate)
30 CAPSULE in 1 BOTTLE, P  133100153077
PDPs
48
MAPDs
QUARTETTE TABLET
(levonorgestrel / ethinyl estradiol)
91 EA  5128504316512
PDPs
76
MAPDs
QUASENSE 0.15-0.03 MG TABLET
(Levonorgestrel & Ethinyl Estradiol (91-Day))
1 KIT in 1 CARTON  5254409669161
PDPs
289
MAPDs
QUDEXY XR 100 MG CAPSULE
(Topiramate)
   0024510741511
PDPs
116
MAPDs
QUDEXY XR 150 MG CAPSULE
(Topiramate)
   0024510751511
PDPs
116
MAPDs
QUDEXY XR 200 MG CAPSULE
(Topiramate)
   0024510731511
PDPs
116
MAPDs
QUDEXY XR 25 MG CAPSULE
(Topiramate)
   0024510711511
PDPs
116
MAPDs
QUDEXY XR 50 MG CAPSULE
(Topiramate)
   0024510721511
PDPs
117
MAPDs
QUESTRAN PACKET 4GM/SCOOP
(Cholestyramine)
60 X 9 GM CRTN498840936654
PDPs
45
MAPDs
QUETIAPINE FUMARATE 100 MG TABLET [Seroquel]
(Quetiapine Fumarate)
100 EA  4733509048867
PDPs
347
MAPDs
QUETIAPINE FUMARATE 200 MG TABLET [Seroquel]
(Quetiapine Fumarate)
100 EA  4733509058867
PDPs
347
MAPDs
QUETIAPINE FUMARATE 25 MG TABLET [Seroquel]
(Quetiapine Fumarate)
100 EA  4733509028867
PDPs
347
MAPDs
QUETIAPINE FUMARATE 300 MG TABLET [Seroquel]
(Quetiapine Fumarate)
100 EA  4733509068867
PDPs
347
MAPDs
QUETIAPINE FUMARATE 400 MG TABLET [Seroquel]
(Quetiapine Fumarate)
100 EA  4733509078867
PDPs
347
MAPDs
QUETIAPINE FUMARATE 50 MG TABLET [Seroquel]
(Quetiapine Fumarate)
100 EA  4733509038867
PDPs
347
MAPDs
QUILLIVANT XR 25 MG/5 ML SUSP
(methylphenidate hydrochloride)
   2447802002010
PDPs
61
MAPDs
QUINAPRIL 10 MG TABLET
(Quinapril)
90 EA  6818005570966
PDPs
345
MAPDs
QUINAPRIL 20 MG TABLET
(Quinapril)
90 EA  3172202699066
PDPs
345
MAPDs
QUINAPRIL 40 MG TABLET
(Quinapril)
90 EA  6818005540966
PDPs
345
MAPDs
QUINAPRIL 5 MG TABLET
(Quinapril)
90 EA  3172202679066
PDPs
345
MAPDs
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 10MG/12.5MG TABLETS
(Quinapril-Hydrochlorothiazide)
90 BOTPL 0037805427764
PDPs
342
MAPDs
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 20MG/12.5MG TABLETS
(Quinapril-Hydrochlorothiazide)
90 BOTPL 0037805437763
PDPs
342
MAPDs
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 20MG/25MG TABLETS
(Quinapril-Hydrochlorothiazide)
90 BOTPL 0037805447764
PDPs
342
MAPDs
Quinidine Gluconate 324mg/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Quinidine Gluconate)
100 TABLET, EXTENDED RELE  5348901410155
PDPs
331
MAPDs
QUINIDINE GLUC 80MG/ML VIAL
(Quinidine Gluconate)
10 ML VIAL0000214070118
PDPs
141
MAPDs
QUINIDINE SULFATE 200 MG TAB
(Quinidine Sulfate)
100 EA  0018543460167
PDPs
346
MAPDs
QUINIDINE SULFATE 300MG TABLET
(Quinidine Sulfate)
100 BOT0059154540167
PDPs
347
MAPDs
QUININE SULFATE 324 MG CAPSULE [Qualaquin]
(Quinine Sulfate)
30 EA  0009330025652
PDPs
304
MAPDs
QVAR 40 MCG ORAL INHALER
(Beclomethasone Dipropionate)
8.7 GM  5931002021264
PDPs
326
MAPDs
QVAR 80 MCG ORAL INHALER
(Beclomethasone Dipropionate)
8.7 GM  5931002041264
PDPs
317
MAPDs
SEROQUEL 100MG TABLET
(Quetiapine Fumarate)
100 BOT003100271109
PDPs
37
MAPDs
SEROQUEL 200MG TABLET
(Quetiapine Fumarate)
100 BOT003100272109
PDPs
37
MAPDs
SEROQUEL 25MG TABLET
(Quetiapine Fumarate)
100 BOT003100275109
PDPs
37
MAPDs
SEROQUEL 300MG TABLET
(Quetiapine Fumarate)
60 BOT003100274609
PDPs
39
MAPDs
SEROQUEL 400MG TABLET
(Quetiapine Fumarate)
100 BOT003100279109
PDPs
39
MAPDs
SEROQUEL 50MG TABLET (100 CT)
(Quetiapine Fumarate)
100 BOT003100278109
PDPs
37
MAPDs
SEROQUEL TABLETS EXTENDED RELEASE 150MG 100 CRTN
(Quetiapine Fumarate)
100 CRTN0031002813965
PDPs
318
MAPDs
SEROQUEL TABLETS EXTENDED RELEASE 200MG 100 X 200 MG CRTN
(Quetiapine Fumarate)
100 X 200 MG CRTN0031002823965
PDPs
318
MAPDs
SEROQUEL XR 300MG TABLET 60X300MG BOT
(Quetiapine Fumarate)
60 X 300 MG BOT0031002836065
PDPs
318
MAPDs
SEROQUEL TABLETS EXTENDED RELEASE 400MG 100 X 400 MG CRTN
(Quetiapine Fumarate)
100 X 400 MG CRTN0031002843965
PDPs
318
MAPDs
SEROQUEL TABLETS EXTENDED RELEASE 50MG 100 TABS CRTN
(Quetiapine Fumarate)
100 TABS CRTN0031002803965
PDPs
318
MAPDs
SYNERCID 500MG VIAL
(Quinupristin-Dalfopristin for)
10 ML VIALGL6157002601067
PDPs
347
MAPDs



(Chart Source: Centers for Medicare and Medicaid files: CMS Data )





Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.